WGS Key Statistics, Chart & Performance
The current stock price of WGS is 127.54 USD. In the past month the price decreased by -21.77%. In the past year, price increased by 61.74%.
WGS Latest News, Press Relases and Analysis
WGS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.64 | 101.20B | ||
| CI | THE CIGNA GROUP | 9.74 | 73.91B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 124.84 | 22.97B | ||
| LH | LABCORP HOLDINGS INC | 15.94 | 20.91B | ||
| DGX | QUEST DIAGNOSTICS INC | 17.87 | 19.40B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.19B | ||
| DVA | DAVITA INC | 12.31 | 8.02B | ||
| HIMS | HIMS & HERS HEALTH INC | 60.17 | 7.40B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 36.96 | 6.80B | ||
| CHE | CHEMED CORP | 19.49 | 6.07B | ||
| RDNT | RADNET INC | 188.16 | 5.52B | ||
| OPCH | OPTION CARE HEALTH INC | 21.58 | 5.10B |
Related stock screener links
About WGS
Company Profile
GeneDx Holdings Corp. operates as a health intelligence company. The company is headquartered in Stamford, Connecticut and currently employs 1,000 full-time employees. The company went IPO on 2020-09-04. The firm operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. The company operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. The company offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
Company Info
GENEDX HOLDINGS CORP
333 Ludlow Street, North Tower, 6Th Floor
Stamford CONNECTICUT US
Employees: 1000
Phone: 18887291206
GENEDX HOLDINGS CORP / WGS FAQ
Can you describe the business of GENEDX HOLDINGS CORP?
GeneDx Holdings Corp. operates as a health intelligence company. The company is headquartered in Stamford, Connecticut and currently employs 1,000 full-time employees. The company went IPO on 2020-09-04. The firm operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. The company operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. The company offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
What is the stock price of GENEDX HOLDINGS CORP today?
The current stock price of WGS is 127.54 USD. The price decreased by -0.36% in the last trading session.
Does WGS stock pay dividends?
WGS does not pay a dividend.
What is the ChartMill technical and fundamental rating of WGS stock?
WGS has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the Price/Earnings (PE) ratio of GENEDX HOLDINGS CORP (WGS)?
The PE ratio for GENEDX HOLDINGS CORP (WGS) is 67.84. This is based on the reported non-GAAP earnings per share of 1.88 and the current share price of 127.54 USD.
What is GENEDX HOLDINGS CORP worth?
GENEDX HOLDINGS CORP (WGS) has a market capitalization of 3.69B USD. This makes WGS a Mid Cap stock.
WGS Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to WGS. When comparing the yearly performance of all stocks, WGS is one of the better performing stocks in the market, outperforming 91.56% of all stocks.
WGS Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to WGS. No worries on liquidiy or solvency for WGS as it has an excellent financial health rating, but there are worries on the profitability.
WGS Financial Highlights
Over the last trailing twelve months WGS reported a non-GAAP Earnings per Share(EPS) of 1.88. The EPS increased by 274.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.52% | ||
| ROA | 0.42% | ||
| ROE | 0.71% | ||
| Debt/Equity | 0.18 |
WGS Forecast & Estimates
13 analysts have analysed WGS and the average price target is 167.51 USD. This implies a price increase of 31.34% is expected in the next year compared to the current price of 127.54.
For the next year, analysts expect an EPS growth of 506% and a revenue growth 47.11% for WGS